EuroProteome

EuroProteome was a German biotechnology company specializing in proteomics-based drug discovery and diagnostic development. Based in Hennigsdorf, the company utilized advanced mass spectrometry and protein separation technologies to identify disease-specific protein patterns and biomarkers. Its primary focus areas included oncology, specifically breast and lung cancers, as well as inflammatory diseases. The company's platform was designed to bridge the gap between genomic data and clinical applications by analyzing the functional state of proteins. In 2005, EuroProteome was acquired by Ciphergen Biosystems to enhance its biomarker discovery and validation services.